These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7480740)

  • 1. Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT.
    Stomper PC; D'Souza DJ; Bakshi SP; Rodriguez-Bigas M; Burke PA; Petrelli NJ
    Radiology; 1995 Dec; 197(3):688-92. PubMed ID: 7480740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels.
    Patt YZ; Podoloff DA; Curley S; Kasi L; Smith R; Bhadkamkar V; Charnsangavej C
    J Clin Oncol; 1994 Mar; 12(3):489-95. PubMed ID: 8120546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials.
    Patt YZ; Podoloff DA; Curley S; Smith R; Badkhamkar VA; Lamki LM; Jessup MM; Hohn DC
    Cancer; 1993 Jun; 71(12 Suppl):4293-7. PubMed ID: 8389662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group.
    Moffat FL; Pinsky CM; Hammershaimb L; Petrelli NJ; Patt YZ; Whaley FS; Goldenberg DM
    J Clin Oncol; 1996 Aug; 14(8):2295-305. PubMed ID: 8708720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody.
    Moffat FL; Vargas-Cuba RD; Serafini AN; Casillas VJ; Morillo G; Benedetto P; Robinson DS; Ardalan B; Manten HD; Clark KC
    Cancer; 1994 Feb; 73(3 Suppl):836-45. PubMed ID: 8306268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer.
    Doerr RJ; Herrera L; Abdel-Nabi H
    Cancer; 1993 Jun; 71(12 Suppl):4241-7. PubMed ID: 8508386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-carcinoembryonic antigen immunoscintigraphy (technetium-99m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma.
    Lind P; Lechner P; Arian-Schad K; Klimpfinger M; Cesnik H; Kammerhuber F; Eber O
    J Nucl Med; 1991 Jul; 32(7):1319-25. PubMed ID: 2066784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioimmunoscintigraphy of colorectal cancer using the anti-CEA monoclonal antibody BW 431/26. Final results].
    Oliva J; Pimentel G; Peralta R; Borrón M; Ortiz R; Gutiérrez J; Guerra J; Quesada W; Dopico R; Casanova F; Baum RP
    Rev Esp Med Nucl; 1999; 18(1):5-15. PubMed ID: 10074212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies.
    Serafini AN; Klein JL; Wolff BG; Baum R; Chetanneau A; Pecking A; Fischman AJ; Hoover HC; Wynant GE; Subramanian R; Goroff DK; Hanna MG
    J Clin Oncol; 1998 May; 16(5):1777-87. PubMed ID: 9586891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of recurrent intestinal carcinoma with indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody CEA102.
    Nakada K; Sakamoto J; Watanabe T; Itoh K; Akiyama S; Takagi H
    Jpn J Cancer Res; 1997 Jun; 88(6):605-13. PubMed ID: 9263539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58.
    Yao YF; Yang Z; Li ZF; Gu J
    World J Gastroenterol; 2007 Mar; 13(12):1841-6. PubMed ID: 17465478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
    Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
    Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticarcinoembryonic antigen immunoscintigraphy with a 99mTc-Fab' fragment (Immu 4) in primary and recurrent colorectal cancer. A prospective study.
    Lechner P; Lind P; Binter G; Cesnik H
    Dis Colon Rectum; 1993 Oct; 36(10):930-5. PubMed ID: 8404384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
    Delaloye B; Bischof-Delaloye A; Buchegger F; von Fliedner V; Grob JP; Volant JC; Pettavel J; Mach JP
    J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 99mTc-IMMU-4 monoclonal antibody scan in colorectal cancer. A prospective study.
    Rodriguez-Bigas MA; Bakshi S; Stomper P; Blumenson LE; Petrelli NJ
    Arch Surg; 1992 Nov; 127(11):1321-4. PubMed ID: 1444794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?
    Fuster D; Maurel J; Muxí A; Setoain X; Ayuso C; Martín F; Ortega ML; Fuertes S; Pons F
    Q J Nucl Med; 2003 Jun; 47(2):109-15. PubMed ID: 12865871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoscintigraphy of colorectal carcinoma with a 99Tcm-labelled anti-CEA monoclonal antibody (BW 431/26).
    Muxí A; Solá M; Bassa P; Pons F; García A; Moragas M; Lomeña F; Herranz R; Fernández R; Trias M
    Nucl Med Commun; 1992 Apr; 13(4):261-70. PubMed ID: 1589179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of CEA antibody scan and computed tomography scan in the follow-up of patients with colorectal cancer].
    García Vicente A; Soriano Castrejón A; González R; Rodado Marina S; Poblete García VM
    Rev Esp Med Nucl; 2002; 21(5):349-55. PubMed ID: 12236910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Typical findings and erroneous findings in SPECT-radioimmunoscintigraphy using 99mTc-labeled CEA antibodies in colorectal tumors].
    Barzen G; Felix R
    Aktuelle Radiol; 1992 Jul; 2(4):212-9. PubMed ID: 1504120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEA-immunoscintigraphy with 99m-technetium correlates with tumour cell differentiation in colorectal cancer.
    Wittig BM; Hach A; Hahn K; Meyer zum Büschenfelde KH; Dippold WG
    Eur J Cancer; 1993; 29A(9):1327-9. PubMed ID: 8343279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.